INSTARELIEF
DEAD

Serial Number

90323484

Owner

DXM Pharmaceutical, Inc.

Attorney

Keith B. Willhelm

Filing Date

Nov 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INSTARELIEF Trademark

Serial Number: 90323484

INSTARELIEF is a trademark filed by DXM Pharmaceutical, Inc. on November 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

DXM Pharmaceutical, Inc. (17 trademarks)

2717 Commercial Center Blvd - Suite E200
Katy, TX 77494

Entity Type: 03

Trademark Details

Filing Date

November 17, 2020

Registration Date

Not Registered

Published for Opposition

June 21, 2022

Goods & Services

over-the-counter cough syrups and other antitussive pharmaceutical preparations for suppressing coughs; over-the-counter energy syrups containing vitamin, mineral, herbal, botanical, amino acid, or other nutritional supplements for boosting energy and other vitamin, mineral, herbal, botanical, amino acid, or other nutritional supplement preparations for boosting energy; over-the-counter anti-allergy syrups and other pharmaceutical preparations for relieving allergy symptoms; over-the-counter antihistamine syrups and other pharmaceutical preparations for relieving allergy symptoms; over-the-counter analgesic syrups and other pharmaceutical preparations for relieving pain; over-the-counter expectorant syrups and other pharmaceutical preparations for relieving bronchial congestion; over-the-counter anti-flatulence syrups and other pharmaceutical preparations for relieving intestinal distress caused by gastro-intestinal gas; over-the-counter decongestant syrups and other pharmaceutical preparations for relieving nasal congestion; over-the-counter drug syrups and other pharmaceutical preparations for treating symptoms of the common cold and influenza; over-the-counter drug syrups and other pharmaceutical preparations containing more than one of the foregoing active ingredients for relieving multiple symptoms, namely, antitussive active ingredients for suppressing coughs, vitamin, mineral, herbal, botanical, amino acid, anti-allergy active ingredients for relieving allergy symptoms, antihistamine active ingredients for relieving allergy symptoms, analgesic active ingredients for relieving pain, expectorant active ingredients for relieving bronchial congestion, anti-flatulence active ingredients for relieving intestinal distress caused by gastro-intestinal gas, decongestant active ingredients for relieving nasal congestion, and drug active ingredients for treating symptoms of the common cold and influenza; and over-the-counter dietary supplement syrups and other preparations being dietary supplements

Filing History

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 8, 2023 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 8, 2023 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 8, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 8, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
Aug 22, 2022 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 19, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 17, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 24, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 24, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 24, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 16, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 20, 2020 NWAP